The Pharmaceutical Source Biotechnology rooftop distributed photovoltaic project undertaken by the group has officially started construction


The Pharmaceutical Source Biotechnology rooftop distributed photovoltaic project undertaken by the group has officially started construction

On November 27th, the groundbreaking ceremony for the 1.98MW rooftop distributed photovoltaic power station project of Yaoyuan Biotechnology Co., Ltd. in Gaohai Construction and Development Co., Ltd., Qidong City, undertaken by the group company, was successfully held. The project utilizes the Pharmaceutical Source Biotechnology roof and adopts a self generated and surplus electricity grid connected power generation mode. The main equipment includes photovoltaic modules, inverters, etc. The project is expected to generate 55 million kWh of electricity during the 25 year operation period. Xu Kaishi, the project team leader of the Limengduo branch responsible for construction, stated that he will adhere to the belief that "starting construction is a decisive battle, every day is a milestone, and the whole process is in sprint", fulfill his duties and do his best to ensure the safety, quality, and progress of the project, and deliver a satisfactory answer to the owner. (Limeng Duo Branch)

Recommended news


The Group dispatched representatives to attend the Exchange Meeting on Construction Project Quality and Safety Management and the On-site Observation Session.

In late September, the China Construction Enterprise Management Association organized an experience-sharing and on-site observation conference on quality and safety management in construction projects in Guangzhou, which was attended by representatives from the Group.


Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an

On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.